AGA IBD Care in a Post-COVID World
0 seconds of 0 secondsVolume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Shortcuts Open/Close/ or ?
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9
3535
AGA IBD Care in a Post-COVID World
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children. In this session, three themes will be discussed that are very relevant to IBD care in a world recovering from and living with COVID. We will discuss immunization and susceptibility to infection in IBD patients. We will consider remote telehealth and patient education to support distance and patient directed care, Finally, we will consider Long-COVID in IBD. Each presentation will consider evidence synthesis in the form of Cochrane and none Cochrane reviews, as well as critically appraising the literature in a manner that supports transparency and clinical utility of findings. After each presentation, our panel of speakers and the moderators will discuss the relevance of the findings in relation to current practice and guidance and explore where gaps exist.
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children. In this session, three themes will be discussed that are very relevant to IBD care in a world recovering from and living with COVID. We will discuss immunization and susceptibility to infection in IBD patients. We will consider remote telehealth and patient education to support distance and patient directed care, Finally, we will consider Long-COVID in IBD. Each presentation will consider evidence synthesis in the form of Cochrane and none Cochrane reviews, as well as critically appraising the literature in a manner that supports transparency and clinical utility of findings. After each presentation, our panel of speakers and the moderators will discuss the relevance of the findings in relation to current practice and guidance and explore where gaps exist.
Moderators
McMaster University
University of Central Lancashire, UK
Related Products
AGA Emerging Concepts in IBD: Fibrosis, Fistulas, Pouches and Frailty
Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations…
AGA Dr. Ellen Scherl — Jill Roberts Lecture — Transforming IBD Care 2: Oral Therapies, Microbiome-Based Therapies, and Diet to Treat IBD
In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
